Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 3/20 | 0.96 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.69 |
| ▸ | HDAC3 | O15379 | 7/20 | 0.67 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.67 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.67 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.67 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.67 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.67 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.67 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.67 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.67 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.67 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.67 |
| ▸ | DRD2 | P14416 | 1/20 | 0.65 |
| ▸ | DRD4 | P21917 | 1/20 | 0.65 |
| ▸ | DRD3 | P35462 | 1/20 | 0.65 |
| ▸ | NPC1 | O15118 | 1/20 | 0.64 |
| ▸ | RAB9A | P51151 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28927370 | 0.98 | NAAA (1.00) | NAAAL3MBTL1SMN1; SMN2HDAC3HDAC1 | |
| SCHEMBL20216434 | 0.98 | NAAA (1.00) | NAAAL3MBTL1SMN1; SMN2HDAC3HDAC1 | |
| SCHEMBL1002638 | 0.98 | NAAA (1.00) | NAAAL3MBTL1SMN1; SMN2HDAC3HDAC1 | |
| SCHEMBL1003239 | 0.98 | NAAA (1.00) | NAAAL3MBTL1SMN1; SMN2HDAC3HDAC1 | |
| SCHEMBL8204741 | 0.98 | NAAA (1.00) | NAAAL3MBTL1SMN1; SMN2HDAC3HDAC1 | |
| Hydrochloric Acid SCHEMBL11612942 | 0.98 | NAAA (0.93) | NAAAL3MBTL1SMN1; SMN2HDAC3HDAC1 | |
| SCHEMBL1004555 | 0.98 | NAAA (1.00) | NAAAL3MBTL1SMN1; SMN2HDAC3HDAC1 | |
| SCHEMBL1002305 | 0.98 | NAAA (1.00) | NAAAL3MBTL1SMN1; SMN2HDAC3HDAC1 | |
| SCHEMBL421014 | 0.98 | NAAA (1.00) | NAAAL3MBTL1SMN1; SMN2HDAC3HDAC1 | |
| SCHEMBL29280581 | 0.98 | NAAA (1.00) | NAAAL3MBTL1SMN1; SMN2HDAC3HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 252 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117229483-A | Amide potassium complex for catalyzing lactide ring-opening polymerization and preparation method thereof | 北京服装学院 | 2023-12-15 | — | — | CN | claimed |
| CN-112107684-A | Methods and compositions for treating ARID2 or HSPA1A mediated diseases | 中国科学院分子细胞科学卓越创新中心 | 2020-12-22 | — | — | CN | claimed |
| CN-108864038-A | 3- amide groups-N- aryl benzamides class compound and preparation and application | 浙江大学 | 2018-11-23 | — | — | CN | claimed |
| CN-102762557-B | Triazolopyridine | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-10-07 | — | — | CN | claimed |
| CN-102762557-A | Triazolopyridines | BAYER SCHERING PHARMA AG | 2012-10-31 | — | — | CN | claimed |
| EP-1888595-A2 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS | XENON PHARMACEUTICALS INC. (CA) | 2008-02-20 | — | — | EP | claimed |
| WO-2006110917-A2 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS | XENON PHARMACEUTICALS INC. (CA) | 2006-10-19 | — | — | WO | claimed |
| US-6037311-A | PLANT PROTECTION COMPOSITIONS BASED ON BENZAMIDE COMPOUND(S) AND CYCLODEXTRIN(S) | ROQUETTE FRERES (FR) | 2000-03-14 | — | — | US | claimed |
| EP-0934264-A1 | PYRROLIDINYL AND PYRROLINYL ETHYLAMINE COMPOUNDS AS KAPPA AGONISTS | PFIZER INC. (US) | 1999-08-11 | — | — | EP | claimed |
| WO-1998012177-A1 | PYRROLIDINYL AND PYRROLINYL ETHYLAMINE COMPOUNDS AS KAPPA AGONISTS | PFIZER INC. (JP) | 1998-03-26 | — | — | WO | claimed |
| CN-1037510-C | Indole derivatives | HOFFMANN LA ROCHE (CH) | 1998-02-25 | — | — | CN | claimed |
| EP-0542973-B1 | PHYTOSANITARY COMPOSITION, METHOD OF PREPARING THE SAME AND USE THEREOF ESPECIALLY FOR COMBATTING WEEDS | ROQUETTE FRERES (FR) | 1996-01-17 | — | — | EP | claimed |
| CN-1088576-A | Indole derivatives | HOFFMANN LA ROCHE (CH) | 1994-06-29 | — | — | CN | claimed |
| EP-0049071-B1 | N-ARYLBENZAMIDE DERIVATIVES | ELI LILLY AND COMPANY (US) | 1984-12-19 | — | — | EP | claimed |
| EP-0049071-A1 | N-arylbenzamide derivatives | ELI LILLY AND COMPANY (US) | 1982-04-07 | — | — | EP | claimed |
| US-12415822-B2 | Small molecule inhibitors selective for polo-like kinase protein | UNIVERSITY OF SOUTH CAROLINA (US) | 2025-09-16 | — | — | US | disclosed |
| US-20250188201-A1 | CATALYST FOR PHOTOCATALYTIC POLYMERIZATION REACTION, AND APPLICATION THEREOF | BEIJING INSTITUTE OF FASHION TECHNOLOGY (CN) | 2025-06-12 | — | — | US | disclosed |
| US-4303664-A | Novel penicillin derivatives containing a coumarin nucleus and medicines containing the same | TEIJIN LIMITED (JP) | 1981-12-01 | — | — | US | disclosed |
| US-4195090-A | ADRENERGIC BLOCKING AGENTS | CIBA-GEIGY CORPORATION (US) | 1980-03-25 | — | — | US | disclosed |
| US-4115575-A | CARDIOVASCULAR DISORDERS | CIBA-GEIGY CORPORATION (US) | 1978-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12415822-B2 | Small molecule inhibitors selective for polo-like kinase protein | PLK2, PLK4, PLK3 | NAAA 2570/4885L3MBTL1 1136/4885SMN1; SMN2 3402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.